Oruka Therapeutics Inc. (NASDAQ: ORKA) announced that its experimental psoriasis treatment ORKA-001 achieved complete skin clearance in 63.5% of patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE